8279.TWO Syngen Biotech Co.,Ltd.

Healthcare Biotechnology Taiwan OTC Exchange
80.30 TWD
Close of Nov 6, 2026
77.60 133.58
Market cap
TWD 2.18B
P/E
10.6x
P/B
0.92x
ROE
9.2%
Dividend yield
6.23%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 8279.TWO undervalued?

Graham number
Price80.30
Graham value121.42
Discount33.9%

8279.TWO trades 33.9% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Syngen Biotech Co.,Ltd. fundamental analysis

No fundamental analysis for Syngen Biotech Co.,Ltd. yet.

Syngen Biotech Co.,Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Syngen Biotech Co.,Ltd.

Syngen Biotech Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan and internationally. The company offers dietary supplements; supplement contract manufacturing services in the form of sachets, liquids, tablets, and capsules; and elderly health care, beauty enhancing supplem…

Full company profile